Arbutus Biopharma 8K Filing
Arbutus Biopharma Corp files 8K with SEC, disclosing changes in leadership and compensation. The filing also includes financial statements and exhibits.
Filed: 2026-05-27 AccNo: 0001447028-26-000024 Size: 10 MB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits